| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |